Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3288092
Max Phase: Preclinical
Molecular Formula: C42H66O8
Molecular Weight: 698.98
Molecule Type: Small molecule
Associated Items:
ID: ALA3288092
Max Phase: Preclinical
Molecular Formula: C42H66O8
Molecular Weight: 698.98
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C(C)[C@@H]1CC[C@@]2(C)[C@H]1[C@H]1CC[C@@H]3[C@@]4(C)CC[C@H](OC(=O)CCCCC(=O)O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)C[C@@H]2OC(=O)CCCCC(=O)O
Standard InChI: InChI=1S/C42H66O8/c1-26(2)27-19-22-40(6)32(50-36(48)16-12-10-14-34(45)46)25-42(8)28(37(27)40)17-18-30-39(5)23-21-31(49-35(47)15-11-9-13-33(43)44)38(3,4)29(39)20-24-41(30,42)7/h27-32,37H,1,9-25H2,2-8H3,(H,43,44)(H,45,46)/t27-,28+,29-,30+,31-,32-,37+,39-,40+,41+,42+/m0/s1
Standard InChI Key: WFDSSHLGLSSCAL-RNMYOVDNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 698.98 | Molecular Weight (Monoisotopic): 698.4758 | AlogP: 9.39 | #Rotatable Bonds: 13 |
Polar Surface Area: 127.20 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.66 | CX Basic pKa: | CX LogP: 8.53 | CX LogD: 2.17 |
Aromatic Rings: 0 | Heavy Atoms: 50 | QED Weighted: 0.11 | Np Likeness Score: 1.95 |
1. Castro MJ, Richmond V, Romero C, Maier MS, Estévez-Braun A, Ravelo AG, Faraoni MB, Murray AP.. (2014) Preparation, anticholinesterase activity and molecular docking of new lupane derivatives., 22 (13): [PMID:24835788] [10.1016/j.bmc.2014.04.050] |
Source(1):